Claire C. Sharpe - Concepedia

Author

Claire C. Sharpe

Also Known As

Bruce Hendry, C C Sharpe, C Pariante, C Sharpe, C. C. Sharpe, C. Sharpe, C.C. Sharpe, CC Sharpe, CLAIRE C. SHARPE, Caroline H. Sharpe

136

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

King's College London King's College Hospital NHS Foundation Trust King's College Hospital University College London Royal Free London NHS Foundation Trust

About

Claire C. Sharpe is an author at King's College London specializing in medicine, molecular physiology, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	554
2	Cell Biology	4	4	265
3	Health Sciences	1	1	119
4	Social Sciences	1	1	56
5	Biostatistics	1	1	86

Claire C. Sharpe

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Journal of the American Heart Association	2016	196
Prevalence and Factors Associated with Hyperkalemia in Predialysis Patients Followed in a Low-Clearance Clinic Pantelis Sarafidis, Rochelle Blacklock, Eleri Wood, Clinical Journal of the American Society of Nephrology	2012	181
Association between hemolysis and albuminuria in adults with sickle cell anemia Thomas G. Day, Emma Drašar, Tony Fulford, Haematologica Glomerular DiseaseImmunohematologyRenal PathologyHemolysis-associated VasculopathyGlomerulonephritis	2011	119
miR-21 and miR-214 Are Consistently Modulated during Renal Injury in Rodent Models Laura Denby, Vasudev Ramdas, Martin McBride, American Journal Of Pathology UrologyMolecular PhysiologyRenal PathologyRenal InflammationRodent Models	2011	108
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system Ernest T. Parker, Linda J. Newby, Claire C. Sharpe, Kidney International Signal TransductionMolecular PhysiologySignaling PathwayCell RegulationReceptor Tyrosine Kinase	2007	87
Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease Ceri Rowe, Alice Sitch, Jonathan Barratt, Kidney International Glomerular DiseaseGlomerulonephritisHemodialysisRenal FunctionRenal Disease	2019	86
How I treat renal complications in sickle cell disease Claire C. Sharpe, Swee Lay Thein Blood	2014	74
COVID-19-related acute kidney injury; incidence, risk factors and outcomes in a large UK cohort Paul Jewell, Kate Bramham, James Galloway, BMC Nephrology	2021	68

Page 1